PATENT CLAIM ANALYSIS

Application Number: 15909801
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["435", "060000"]

Abstract:
The present invention provides compounds of the formula: which are useful as inhibitors of PHD, pharmaceutical compositions thereof, methods for treatment of conditions associated with HIF, processes for making the compounds and intermediates thereof.

Claim (Index 17):
A pharmaceutical composition comprising a compound or pharmaceutically acceptable salt as defined in  claim 12 , and a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 90.0
- Lexical Diversity: 1.25806
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14693110', '14226722', '15150976', '16080506', '15620620']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6150597914572214
- 35 USC 102 Novelty (BERT): 0.5352505174391811
- Combined Prediction Score: 0.6070788640554174
- Mean Citation Score: 359.5609760000001
- Max Citation Score: 367.1524
- Similarity Product: 240.288906031704

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test